Consumer staples are often treated as a single defensive bucket, but not all staples ETFs are built the same way. The Fidelity MSCI Consumer Staples Index ETF (FSTA) and the First Trust Consumer Staples AlphaDEX Fund (FXG) both provide U.S. exposure to everyday-product companies, yet they pursue that goal through very different methodologies. FSTA is a broad, low-cost index fund that mirrors the full staples universe, while FXG applies a quantitative "AlphaDEX" factor screen to concentrate in a smaller set of names. As investors weigh defensiveness against income and growth amid shifting inflation, rate, and consumer-spending signals, an ETF comparison of these two funds clarifies how structure and cost drive relative positioning.
FSTA is a passively managed fund that seeks to replicate the performance of the MSCI USA IMI Consumer Staples 25/50 Index, a market-capitalization-weighted benchmark spanning large-, mid-, and small-cap U.S. staples companies. The portfolio holds roughly 100 securities, with nearly all assets in consumer defensive names and only minor allocations to consumer cyclical stocks. Its top positions reflect a pronounced mega-cap tilt: WMT, COST, PG, KO, and PEP account for a large share of assets, followed by PM, MO, MDLZ, CL, and MNST. The expense ratio is 0.08%, among the lowest in the category, and the fund's sizable asset base supports tight bid-ask spreads and robust daily liquidity.
FXG tracks the StrataQuant Consumer Staples Index, a rules-based benchmark that applies the AlphaDEX methodology to the Russell 1000 universe. The index ranks stocks on both growth factors (price appreciation, sales growth, sales-to-price) and value factors (book-to-price, cash-flow-to-price, return on assets), then weights the higher-ranked quintiles more heavily. The result is a modified equal-dollar-weighted portfolio of about 41 holdings that is rebalanced and reconstituted quarterly. Top positions typically include CAH, FRPT, POST, PPC, MKC, INGR, SFD, and STZ, each near a 4% weight. Because the screen includes distribution and healthcare-adjacent names such as MCK, FXG carries a meaningful healthcare allocation alongside its consumer-defensive core. Its expense ratio is 0.63%, and the fund's smaller asset base results in lighter average trading volume.
Both funds operate within the consumer staples complex, which has historically served as a defensive anchor during periods of economic uncertainty. Recent market cycles have, however, pressured the sector through a combination of input-cost inflation, cautious consumer-spending patterns, and shifting trade and tariff dynamics affecting packaged-food and beverage producers. Branded consumer staples companies have also contended with private-label competition and volume declines as shoppers trade down. At the same time, staples' reliable cash flows and dividend streams remain attractive when interest-rate expectations favor yield and stability over high-growth momentum. Within this environment, the divergence between broad, mega-cap staples exposure (FSTA) and factor-tilted, mid-cap food and distribution exposure (FXG) has widened, with the quality-heavy index approach generally showing steadier fund performance than the more concentrated AlphaDEX portfolio in recent months.
Over recent weeks and months, FSTA has demonstrated more consistent trend behavior than FXG, reflecting its heavy concentration in large, well-capitalized staples franchises with pricing power and global scale. FXG's factor-driven tilt toward mid-cap food, agricultural, and distribution companies has left it more exposed to commodity volatility, input-cost swings, and idiosyncratic earnings surprises. The two funds also differ in volatility profile: FSTA's mega-cap orientation and deeper liquidity generally support lower relative drawdowns, while FXG's smaller holdings and concentrated roster can amplify short-term swings. From a cost standpoint, FSTA's 0.08% expense ratio versus FXG's 0.63% represents a persistent structural advantage that compounds over time. Sector rotation toward defensive quality has favored FSTA's core names, whereas FXG's relative positioning has been more sensitive to shifts in food-commodity prices and healthcare distribution trends.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs with customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is built to surface trade ideas, trending names, breakout candidates, and market opportunities more efficiently than manual screening, saving time while sharpening the research process. Whether comparing sector ETFs or hunting for individual setups, the AI Screener provides a structured, data-driven starting point for deeper analysis.
Based on observable structural factors, Tickeron's AI would currently favor FSTA. The fund combines a materially lower expense ratio, a broader and more liquid portfolio, deeper diversification, and a mega-cap quality tilt that has supported steadier trend consistency through recent market cycles. FXG's factor methodology offers a legitimate alternative for investors seeking value and growth tilts within staples, but its higher cost, concentrated holdings, thinner trading volume, and greater sensitivity to commodity and idiosyncratic risks place it at a relative disadvantage in the current environment. Accordingly, FSTA presents the stronger balance of cost efficiency, diversification, and risk-adjusted positioning between the two funds.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for FSTA crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on FSTA as a result. In 71 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for FSTA just turned positive on October 07, 2026. Looking at past instances where FSTA's MACD turned positive, the stock continued to rise in 39 of 45 cases over the following month. The odds of a continued upward trend are 87%.
FSTA moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +0.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where FSTA advanced for three days, in 251 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 234 of 316 cases where FSTA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
The 10-day RSI Indicator for FSTA moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 30 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FSTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
FSTA broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The 10-day moving average for FXG crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 84%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on FXG as a result. In 72 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
FXG moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXG advanced for three days, in 258 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 181 of 273 cases where FXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
FXG broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
| FSTA | FXG | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 83% | N/A |
| Stochastic ODDS (%) | 1 day ago 71% | 1 day ago 79% |
| Momentum ODDS (%) | 4 days ago 73% | 1 day ago 77% |
| MACD ODDS (%) | 7 days ago 87% | N/A |
| TrendWeek ODDS (%) | 1 day ago 74% | 1 day ago 75% |
| TrendMonth ODDS (%) | 1 day ago 78% | 1 day ago 74% |
| Advances ODDS (%) | 1 day ago 78% | 11 days ago 82% |
| Declines ODDS (%) | 7 days ago 75% | 7 days ago 76% |
| BollingerBands ODDS (%) | 1 day ago 70% | 1 day ago 73% |
| Aroon ODDS (%) | 1 day ago 74% | 1 day ago 66% |
A.I.dvisor indicates that over the last year, FSTA has been closely correlated with CL. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if FSTA jumps, then CL could also see price increases.
| Ticker / NAME | Correlation To FSTA | 1D Price Change % | ||
|---|---|---|---|---|
| FSTA | 100% | +0.36% | ||
| CL - FSTA | 75% Closely correlated | -0.09% | ||
| PG - FSTA | 74% Closely correlated | -0.59% | ||
| CAG - FSTA | 65% Loosely correlated | -2.37% | ||
| GIS - FSTA | 61% Loosely correlated | -1.13% | ||
| HSY - FSTA | 60% Loosely correlated | +1.43% | ||
More | ||||
A.I.dvisor indicates that over the last year, FXG has been closely correlated with CAG. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if FXG jumps, then CAG could also see price increases.